Arzeda to Lead Major NSF-Funded Initiative Advancing Electricity-Driven Cell-Free Biomanufacturing Through AI-Designed Enzymes

Consortium project totaling $7.8 million to develop foundational technology to position bioelectrochemistry as commercially viable for difficult challenges such as CO₂ conversion

SEATTLE, Sept. 30, 2025 /PRNewswire/ -- Arzeda, The Protein Design Company™, today announced it has been selected to lead a highly competitive U.S. National Science Foundation (NSF) award under the Ideas Lab: Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications (NSF CFIRE) initiative. The award, totaling approximately $7.8 million, will harness Arzeda's Intelligent Protein Design Technology™ to develop electricity-powered enzyme cascades for sustainable chemical production. This award complements Arzeda's NSF USPRD selection announced a couple weeks ago, together advancing AI-designed enzymes and cell-free manufacturing.

"Electricity-driven biology unlocks a new manufacturing paradigm," said Alexandre Zanghellini, Ph.D., cofounder and CEO of Arzeda and Principal Investigator on the award. "With AI-designed enzymes that run directly on electrons, we can bypass many limitations of living cells and build cleaner, more efficient routes for difficult-to-synthesize critical chemicals like methanol."

Transforming Bioelectrochemistry

• Achieving High Efficiency: Design AI-powered enzymes and cascades targeting >70% energy efficiency, overcoming the >50% energy losses typical of chemical electrocatalysis approaches.
  
  
• Converting CO₂ to Value: Create cell-free cascades to transform waste CO₂ into methanol, a key fuel and chemical feedstock.
  
  
• Momentum from USPRD: Builds on Arzeda's NSF USPRD award announced earlier this month, which accelerates AI-driven protein design for cell-free manufacturing.

Collaborative Ecosystem

Under the award, Arzeda will lead a consortium of academia and industry, including Missouri University of Science and Technology and Novonesis A/S [OTC: NVZMY], a global leader in industrial enzyme manufacturing. The multidisciplinary team will integrate AI enzyme design, synthetic chemistry, and electrochemical engineering to advance cell-free bioelectrodes for industrial adoption.

NSF Acknowledgment

Research reported in this release is supported by the U.S. National Science Foundation: NSF CFIRE award #2453663. Any opinions, findings, and conclusions or recommendations expressed are those of the authors and do not necessarily reflect the views of the NSF. NSF award announcement: https://www.nsf.gov/tip/updates/nsf-invests-more-32m-biotechnology-accelerating-adoption.

About Arzeda

Arzeda develops innovative products powered by its Intelligent Protein Design Technology™, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. We commercialize with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing, more cost-effective solutions that are healthier and sustainable. For more information, please visit www.arzeda.com.

Media Contact
[email protected]

SOURCE Arzeda